CMAX BIOTECH CONSULTING

Hasselt ·KBO/BCE: BE 0784.922.317

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	37.4%	55.0%	better than 36% of 174 sector peers
Net result	€75k	€16k	better than 80% of 174 sector peers
Equity	€77k	€70k	better than 52% of 174 sector peers
Gross operating margin	€98k	€41k	better than 73% of 175 sector peers
Total assets	€207k	€145k	better than 63% of 175 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€207k
Fixed assets	21/28	€3k
Tangible fixed assets	22/27	€3k
Current assets	29/58	€204k
Amounts receivable within one year	40/41	€36k
Cash & bank	54/58	€168k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€207k
Equity	10/15	€77k
Contributions / capital	10/11	€4k
Accumulated profits (losses)	14	€73k
Amounts payable	17/49	€129k
Amounts payable within one year	42/48	€129k
Trade debts payable within one year	44	€10k
Income statement
Gross operating margin	9900	€98k
Operating result	9901	€96k
Financial income	75	€192
Financial charges	65	€1k
Result before taxes	9903	€95k
Income taxes	67/77	€20k
Net result for the period	9904	€75k
Result to be appropriated	9905	€75k

Summary